Life sciences briefing: Wednesday, Jan. 23, 2008
TODAY’S HEADLINES:
Mauna Kea Tech raises $30M for in-vivo cellular imaging (release)
Knopp Neuro takes in $10M for Lou Gehrig’s drug (release)
Cardiovascular Systems, arterial-plaque device maker, files for $86M IPO (Edgar)
Diagnostics maker BG Medicine withdraws IPO (release)
Signature Genomics Labs sells stake to Ampersand Ventures (release)
Cambridge Temp raises… Continue Reading
Life sciences briefing: Thursday, Oct. 11, 2007
Featured companies: Ablynx, Bind Biosciences, Maas Biolab, Oriel Therapeutics, ThromboVision, Xcellerex
(UPDATED: See below.)
Contract biomanufacturer Xcellerex pulls in $31M — Marlborough, Mass.-based Xcellerex, a startup that provides contract “bioprocess” development and manufacturing, raised $31 million in a third funding round. Investors included VantagePoint Venture Partners, Kleiner Perkins… Continue Reading
Life sciences briefing: Wednesday, Sept. 5, 2007
Featured companies: Atritech, Avalon Partners, Ensemble Discovery, Hyperion Therapeutics, LifeBond, ReShape Medical, SafeStitch, Trophos, UltraShape
Hyperion Therapeutics raises $40M against GI and kidney disease — Hyperion Therapeutics, a South San Francisco, Calif., specialty pharmaceutical company, raised $40 million in a second funding round. Investors included Sofinnova Ventures,… Continue Reading